News

Russia admits WHO yet to approve Sputnik jab over lack of data

December 14, 2021 07:44 PM


Twitter Share Facebook Share WhatsApp Share

Russia on Tuesday admitted that its homegrown Sputnik V coronavirus vaccine had not yet been approved by the World Health Organization because Russian authorities had not provided enough data.

In August last year, Sputnik V became the world's first approved coronavirus vaccine, when Russian authorities gave it the green light for domestic use ahead of large-scale clinical trials.

"We still haven't provided certain information that needs to be provided for certification because we had a different understanding of what information it had to be and how it should be provided," Kremlin spokesman Dmitry Peskov told reporters. 

"We have different standards." 

But Peskov said Russia is "gradually, let's say, adapting to these requirements." 

While officials sparked concerns over the fast-track process, the jab was since declared safe and more than 90 percent effective in a report published by leading medical journal The Lancet. 

But neither the US nor EU medicines watchdogs have so far granted authorisation for Sputnik V, which has been used in Russia and a host of other countries since late last year.

The WHO last month said it had restarted the certification process that could grant emergency authorisation for Sputnik V after delaying the process for several months but said it still needed "the full dossier on Sputnik". 

At home, Russian authorities have faced a vaccine-sceptic population that has seen just 42 percent of Russians fully inoculated.   

A Twitter account associated with jailed opposition leader Alexei Navalny on Tuesday blamed the delayed WHO certification process on the Russian authorities and said that it had contributed to vaccine-scepticism at home.

"People are dying and they are sorting through paper," the account tweeted.  

The WHO has so far granted emergency authorisations to Covid-19 shots Pfizer-BioNTech, Moderna, AstraZeneca, Johnson&Johnson, Sinopharm, Sinovac and India's Bharat Biotech.

 

 



Most Read

  1. Five more children die as death toll from measles in Dadu reaches 27 Five more children die as death toll from measles in Dadu reaches 27
  2. Zuhab Khan and Wania Nadeem's love story culminates in heartfelt Nikah ceremony Zuhab Khan and Wania Nadeem's love story culminates in heartfelt Nikah ceremony
  3. Sharmin Segal says NO to Salman Khan's marriage proposal Sharmin Segal says NO to Salman Khan's marriage proposal
  4. Ahmed Ali Akbar drops clue of ‘Parizaad’ Season 2 Ahmed Ali Akbar drops clue of ‘Parizaad’ Season 2
  5. 'Arrogant' student hurls bolttle at Indian singer Sunidhi Chauhan's face during concert 'Arrogant' student hurls bolttle at Indian singer Sunidhi Chauhan's face during concert
  6. Fan kisses Durefishan Saleem at Ishq Murshid cinema screening Fan kisses Durefishan Saleem at Ishq Murshid cinema screening

Opinion

  1. 9th May - A year later
    9th May - A year later

    By Mutaza Solangi

  2. Everything but the truth in Telegraph
    Everything but the truth in Telegraph

    By Mutaza Solangi

  3. PM Shehbaz Sharif, WEF and Pakistan
    PM Shehbaz Sharif, WEF and Pakistan

    By Naveed Aman Khan

  4. Employing global best practices in Pakistan-Saudi ties
    Employing global best practices in Pakistan-Saudi ties

    By Nasim Zehra

  5. PML-N smashed PTI in by-polls
    PML-N smashed PTI in by-polls

    By News Desk

  6. Riding the Digital Wave: How Technology is Rewriting the Script of Economic Prosperity
    Riding the Digital Wave: How Technology is Rewriting the Script of Economic Prosperity

    By News Desk